{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:53:51Z","timestamp":1778954031703,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030112"],"award-info":[{"award-number":["82030112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273853"],"award-info":[{"award-number":["82273853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574323"],"award-info":[{"award-number":["82574323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25JS2830100"],"award-info":[{"award-number":["25JS2830100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24JS2830100"],"award-info":[{"award-number":["24JS2830100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1474900"],"award-info":[{"award-number":["23ZR1474900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1413700"],"award-info":[{"award-number":["24ZR1413700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2024CXPT029"],"award-info":[{"award-number":["2024CXPT029"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118591","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:43:19Z","timestamp":1768664599000},"page":"118591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure-activity relationship of N-cyclopropylmethyl-7\u03b1-(m-methylaminophenyl)-6,14-endoethano-northebaine derivatives as G-protein-biased KOR-selective agonists"],"prefix":"10.1016","volume":"306","author":[{"given":"Siyuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangwen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoliang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denggao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinggen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-3839","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118591_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1358\/dof.2019.44.1.2885875","article-title":"kappa-Opioid receptor agonists in pain treatment","volume":"44","author":"Pergolizzi","year":"2019","journal-title":"Drug Future"},{"key":"10.1016\/j.ejmech.2026.118591_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: new directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib3","article-title":"Cortical kappa opioid receptors integrate negative affect and sleep disturbance","volume":"14","author":"Vizin","year":"2024","journal-title":"Transl Psychiat"},{"key":"10.1016\/j.ejmech.2026.118591_bib4","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1111\/bph.70097","article-title":"Opioid receptors in cardiovascular function","volume":"182","author":"Katari","year":"2025","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.ejmech.2026.118591_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00221-025-07066-z","article-title":"Supraspinal kappa-opioid receptors: new therapeutic strategies for pain, pruritus, and negative emotions","volume":"243","author":"Zhang","year":"2025","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejmech.2026.118591_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010346","article-title":"Design of kappa-Opioid receptor agonists for the development of potential treatments of pain with reduced side effects","volume":"28","author":"Santino","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118591_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41398-025-03638-3","article-title":"The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies","volume":"15","author":"Zurrer","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.118591_bib8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","article-title":"Difelikefalin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2026.118591_bib9","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1038\/s41467-025-60013-y","article-title":"HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials","volume":"16","author":"Zhong","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118591_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00407","article-title":"A review of the therapeutic potential of recently developed G protein-biased Kappa agonists","volume":"10","author":"Mores","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118591_bib11","doi-asserted-by":"crossref","first-page":"eaav0320","DOI":"10.1126\/scisignal.aav0320","article-title":"Biased ligands at opioid receptors: current status and future directions","volume":"14","author":"Che","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.118591_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.118591_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.120.000134","article-title":"Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side effects","volume":"375","author":"Paton","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2026.118591_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1248\/cpb.46.366","article-title":"Discovery of a structurally novel opioid \u03ba-agonist derived from 4,5-epoxymorphinan","volume":"46","author":"Nagase","year":"1998","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.ejmech.2026.118591_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","article-title":"Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions","volume":"995","author":"Suzuki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2026.118591_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/164_2021_443","article-title":"Preclinical studies on Nalfurafine (TRK-820), a clinically used KOR agonist","volume":"271","author":"Zhou","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118591_bib17","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1021\/acs.jmedchem.9b00857","article-title":"Discovery of a highly selective and Potent kappa opioid receptor agonist from N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaines with reduced Central Nervous System (CNS) side effects navigated by the message-address concept","volume":"62","author":"Xiao","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib18","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1021\/acs.jmedchem.1c01082","article-title":"Discovery of an M-Substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaine as a selective, potent, and orally active kappa-Opioid receptor agonist with an improved central nervous system safety profile","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib19","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1021\/acs.jmedchem.2c00014","article-title":"SLL-627 is a highly selective and potent Kappa Opioid Receptor (KOR) agonist with an unexpected nonreduction in locomotor activity","volume":"65","author":"Kong","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib20","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1021\/acs.jmedchem.3c02439","article-title":"Discovery of an ortho-substituted -Cyclopropylmethyl-7\u03b1-phenyl-6,14-ethano-tetrahydronorthebaine derivative as a selective and Potent Kappa Opioid receptor agonist with subsided sedative effect","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib21","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1021\/acs.jmedchem.5c00882","article-title":"Structure-Activity relationship of N-Cyclopropylmethyl-7alpha-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as potent and selective Kappa Opioid receptor agonists","volume":"68","author":"Kong","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115589","article-title":"Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthone","volume":"258","author":"Kong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117449","article-title":"Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR\/MOR activities","volume":"289","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118373","article-title":"Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonists","volume":"130","author":"Zhang","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/acschemneuro.1c00034","article-title":"Exploration of the SAR connection between Morphinan- and Arylacetamide-Based kappa Opioid receptor (kappa OR) agonists using the strategy of bridging","volume":"12","author":"Liu","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118591_bib26","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1016\/j.bmc.2018.07.020","article-title":"7 beta-Methyl substituent is a structural locus associated with activity cliff for nepenthone analogues","volume":"26","author":"Sun","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41401-021-00761-x","article-title":"Novel selective kappa agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion","volume":"43","author":"Wei","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.118591_bib28","first-page":"371","article-title":"Synthesis of the new thebaine derivatives by the Diels-Alder reaction with northebaine","volume":"32","author":"Kim","year":"1988","journal-title":"J. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118591_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2008.02.028","article-title":"LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential","volume":"584","author":"Tao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118591_bib30","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1021\/acs.jmedchem.4c00646","article-title":"Systematic structure-activity relationship Study of nalfurafine analogues toward development of potentially nonaddictive pain management treatments","volume":"67","author":"St Onge","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118591_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.drugalcdep.2024.112000","article-title":"Nalfurafine is aversive at Analgesic Doses- Non- clinical evidence to indicate it is not an atypical Kappa opioid receptor agonist","volume":"267","author":"Kuijer","year":"2025","journal-title":"Drug Alcohol Depen"},{"key":"10.1016\/j.ejmech.2026.118591_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106091","article-title":"An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects","volume":"177","author":"French","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118591_bib33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41467-023-37041-7","article-title":"Molecular mechanism of biased signaling at the kappa opioid receptor","volume":"14","author":"El Daibani","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118591_bib34","article-title":"Signaling underlying kappa opioid receptor-mediated behaviors in rodents","volume":"16","author":"Liu-Chen","year":"2022","journal-title":"Front Neurosci-Switz"},{"key":"10.1016\/j.ejmech.2026.118591_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1476-5381.1987.tb11281.x","article-title":"Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to Mu-Opioid and kappa-opioid receptor agonists","volume":"91","author":"Hayes","year":"1987","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.ejmech.2026.118591_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1476-5381.1980.tb07041.x","article-title":"A classification of opiate receptors that mediate antinociception in animals","volume":"69","author":"Tyers","year":"1980","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.ejmech.2026.118591_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30030604","article-title":"Effects of biased analogues of the Kappa Opioid receptor agonist, U50,488, in preclinical models of pain and side effects","volume":"30","author":"van de Wetering","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118591_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110061","article-title":"Limitations and potential of \u03baOR biased agonists for pain and itch management","volume":"258","author":"El Daibani","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118591_bib39","first-page":"431","article-title":"G protein signaling-biased Kappa opioid receptor agonists produce anxiolytic-like effects in mice","volume":"49","author":"Bohn","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2026.118591_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/jpet.114.216820","article-title":"The G protein-biased \u03ba-Opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo","volume":"352","author":"White","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2026.118591_bib41","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1016\/j.cell.2025.10.022","article-title":"Pathway-selective 5-HT(1A)R agonist as a rapid antidepressant strategy","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118591_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-025-09643-2","article-title":"Designing allosteric modulators to change GPCR G protein subtype selectivity","volume":"648","author":"Moore","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118591_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44386-025-00011-8","article-title":"Intracellular GPCR modulators enable precision pharmacology","volume":"2","author":"Krumm","year":"2025","journal-title":"NPJ Drug Discov"},{"key":"10.1016\/j.ejmech.2026.118591_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41573-024-01083-3","article-title":"Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery","volume":"24","author":"Conflitti","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118591_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-023-06030-7","article-title":"Ligand and G-protein selectivity in the.kappa-opioid receptor","volume":"617","author":"Han","year":"2023","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:47:11Z","timestamp":1773971231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S022352342600036X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118591","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship of N-cyclopropylmethyl-7\u03b1-(m-methylaminophenyl)-6,14-endoethano-northebaine derivatives as G-protein-biased KOR-selective agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118591"}}